GSK and Vir to expand Covid-19 antibody treatment study
Phase III study will be conducted on around 1,300 non-hospitalised patients globally. Credit: Thor Deichmann from Pixabay.
Learn more
Hover over the logos to learn more about the companies who made this project possible.
-
Malvern Panalytical
Malvern Panalytical offers characterisation tools for molecular analysis and small...
About
Malvern Panalytical offers characterisation tools for molecular analysis and small drug discovery to help accelerate development for the pharmaceutical industry.
FollowMake an Enquiry
-
MIT Optimal Sourcing Solutions
MIT Optimal Sourcing Solutions is a dedicated supplier of comparator...
About
MIT Optimal Sourcing Solutions is a dedicated supplier of comparator drugs, specialised in European Union (EU) open market solutions for clinical trials.
FollowMake an Enquiry
-
KPS
Founded in 2010, KPS is a Functional Service Provider (FSP)...
About
Founded in 2010, KPS is a Functional Service Provider (FSP) offering Clinical Monitoring, Project Management and CRO Oversight solutions to the biopharmaceutical industry.
FollowMake an Enquiry